1. Home
  2. SEAT vs ATYR Comparison

SEAT vs ATYR Comparison

Compare SEAT & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivid Seats Inc.

SEAT

Vivid Seats Inc.

N/A

Current Price

$6.10

Market Cap

66.0M

Sector

Industrials

ML Signal

N/A

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

N/A

Current Price

$0.92

Market Cap

69.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SEAT
ATYR
Founded
2001
2005
Country
United States
United States
Employees
768
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.0M
69.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SEAT
ATYR
Price
$6.10
$0.92
Analyst Decision
Buy
Hold
Analyst Count
8
8
Target Price
$32.94
$4.20
AVG Volume (30 Days)
95.5K
1.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9,628.95
Revenue Next Year
N/A
$156.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.42
$0.64
52 Week High
$35.00
$7.29

Technical Indicators

Market Signals
Indicator
SEAT
ATYR
Relative Strength Index (RSI) 45.73 50.02
Support Level $5.94 $0.67
Resistance Level $7.84 $1.09
Average True Range (ATR) 0.67 0.07
MACD 0.04 -0.01
Stochastic Oscillator 33.03 34.82

Price Performance

Historical Comparison
SEAT
ATYR

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: